Genome Editing/Genome Engineering Market Size, Share, Forecast Report, 2020-2027
The global Genome Editing/Genome Engineering market garnered revenue around USD 5.2 Billion in 2020 and projected to reach USD 11.6 Billion by 2027, with at a compound annual growth rate (CAGR) of 17.8% throughout the estimate period from 2020 to 2027. Market growth is largely driven by factors such as the availability of government funding and growth in the number of genomics projects. However, the high cost of genomic equipment will restrain the growth of this market.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Genome Editing/Genome Engineering market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Genome Editing/Genome Engineering market growth.
The global Genome Editing/Genome Engineering market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited (UK), Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), Sangamo Therapeutics (US), Editas Medicine (US), CRISPR Therapeutics (Switzerland), Precision Biosciences (US), Oxford Genetics (UK), Intellia Therapeutics (US), Synthego (US), Vigene Biosciences (US), EpiGenie (US), Integrated DNA Technologies (US), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Creative Biogene (US), Agilent Technologies (US), Danaher (US), ToolGen (South Korea), Cellecta (US), Genecopoeia (US), and Calyxt (US)
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
- Other Technologies
- Cell Line Engineering
- Genetic Engineering
- Diagnostic Applications
- Drug Discovery & Development
- Other Applications
By Product & Service
- Reagents & Consumables
- Software & Systems
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Government Research Institutes
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
- United States
- United Kingdom
- Rest of EU
- Southeast Asia
- Rest of APAC
Central & South America
- Rest of Central & South America
Middle East and Africa
- Saudi Arabia
- Rest of MEA